Literature DB >> 24611663

Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma.

André Goy1, Mark Berger, Peggy Ford, Tatyana Feldman, Anthony Mato, Colleen Bejot, Henry C Fung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24611663     DOI： 10.3109/10428194.2014.900760

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  5 in total

Review 1.  Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers in Lymphoid Malignancies.

Authors:  Ruifang Sun; Jinfen Wang; Ken H Young
Journal:  Crit Rev Oncog       Date:  2017

2.  Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1.

Authors:  Jung-Chen Su; Chuan-Hsun Chang; Szu-Hsien Wu; Chung-Wai Shiau
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

Review 3.  Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer.

Authors:  Natalie Yan Li Ngoi; Clarice Choong; Joanne Lee; Gregory Bellot; Andrea Li Ann Wong; Boon Cher Goh; Shazib Pervaiz
Journal:  Cancers (Basel)       Date:  2020-03-02       Impact factor: 6.639

Review 4.  Critically dysregulated signaling pathways and clinical utility of the pathway biomarkers in lymphoid malignancies.

Authors:  Rui-Fang Sun; Qian-Qian Yu; Ken H Young
Journal:  Chronic Dis Transl Med       Date:  2018-03-12

Review 5.  BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas.

Authors:  Magdalena Klanova; Pavel Klener
Journal:  Cancers (Basel)       Date:  2020-04-10       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.